NICE backs Allergan’s Ozurdex, AbbVie’s Humira for uveitis
Cost regulators for the NHS in England and Wales are backing routine use of Allergan’s Ozurdex and AbbVie’s Humira to treat non-infectious posterior uveitis, a form of preventable vision loss.
Read More
